8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2002 / Sequential nonrandomized intervention study
Researchers tested sequential 6-week daily treatments of 25 mcg, 100 mcg, and 1,000 mcg oral cobalamin in 23 older adults with cobalamin deficiency. Daily treatment with 25 mcg and 100 mcg lowered but did not normalize MMA levels in most participants, whereas 1,000 mcg/day was the most effective in lowering MMA to normal limits. Serum tHcy normalized in 6 of 11 participants with elevated baseline tHcy using oral cobalamin alone, and in 1 participant in combination with a multivitamin.
Rajan S, Wallace JI, Brodkin KI, et al. J Am Geriatr Soc, 2002. PMID 12410896
2001 / Pre-post intervention trial
In a three-stage trial of 52 healthy middle-aged and elderly volunteers, consuming 10^9 CFUs/g of Lactobacillus rhamnosus HN001 in milk for 3 weeks increased polymorphonuclear cell phagocytic activity by 19% in regular low-fat milk and 15% in lactose-hydrolyzed milk. Natural killer cell tumor killing activity also rose by 71% and 147%, respectively. Responses were not altered during the milk-only run-in period.
Sheih YH, Chiang BL, Wang LH, et al. J Am Coll Nutr, 2001. PMID 11349938
2001 / Randomized controlled split-body trial
Postmenopausal women applied a topical vitamin C preparation to one forearm and a placebo to the other forearm, followed by bilateral biopsies to measure dermal mRNA levels. Topical vitamin C similarly increased mRNA levels of collagen types I and III, three post-translational processing enzymes (carboxy- and amino-procollagen proteinases, lysyloxidase), decorin, and tissue inhibitor of matrix metalloproteinase 1 (TIMP-1). It did not alter mRNA levels of elastin, fibrillin 1 and 2, MMPs 1, 2, and 9, or TIMP-2. The stimulating effect of topical vitamin C was most pronounced in women with the lowest dietary intake of the vitamin.
Nusgens BV, Humbert P, Rougier A, et al. J Invest Dermatol, 2001. PMID 11407971
2001 / 3-stage dietary supplementation trial (run-in, intervention, washout)
Thirty healthy elderly volunteers took part in a 9-week, 3-stage trial comprising a 3-week low-fat milk run-in, a 3-week intervention with milk supplemented with Bifidobacterium lactis HN019 (either 5 x 10^10 or 5 x 10^9 organisms/day), and a 3-week milk washout. Consumption of B. lactis HN019 led to increases in proportions of total, helper (CD4+), and activated (CD25+) T lymphocytes and natural killer cells. In addition, ex vivo phagocytic capacity of phagocytes and tumoricidal activity of natural killer cells were elevated, with the greatest changes seen in participants with poor pretreatment immune responses. The two doses showed similar effectiveness overall.
Gill HS, Rutherfurd KJ, Cross ML, et al. Am J Clin Nutr, 2001. PMID 11722966
2000 / Non-randomized controlled trial (5-year follow-up)
Eighteen postmenopausal women who previously completed a 9-month intervention volunteered for a 5-year follow-up trial. Nine engaged in weighted vest plus jumping exercise three times per week for 32 weeks per year over 5 years, while nine controls remained active without the program. After 5 years, changes in BMD for exercisers were +1.54% +/- 2.37%, -0.24% +/- 1.02%, and -0.82% +/- 1.04% at the femoral neck, trochanter, and total hip, respectively, compared to decreases of -4.43% +/- 0.93%, -3.43% +/- 1.09%, and -3.80% +/- 1.03% in controls.
Snow CM, Shaw JM, Winters KM, et al. J Gerontol A Biol Sci Med Sci, 2000. PMID 10995045
2000 / 3-month open-label study
Researchers conducted a 3-month open-label study administering 10 mg/day of oral reduced nicotinamide adenine dinucleotide (NADH) to 25 patients with mild to moderate dementia alongside their current cholinomimetic medication. Among the 19 patients who completed the study, no evidence was found for any cognitive effect assessed by established psychometric tests. The authors concluded that NADH is unlikely to produce cognitive improvements of the magnitude reported earlier.
Rainer M, Kraxberger E, Haushofer M, et al. J Neural Transm (Vienna), 2000. PMID 11459000
1999 / Randomized, double-blind, vehicle-controlled split-face trial
Nineteen patients with mild to moderate facial photodamage applied topical ascorbic acid to one side of the face and a vehicle serum to the other daily for 3 months. Optical profilometry demonstrated a statistically significant 73.7% improvement in Ra and shadows north-south facial axis values favoring active treatment over vehicle control, along with a trend toward improvement in Rz (68.4% greater improvement). Clinical assessments showed significant improvements in fine wrinkling, tactile roughness, coarse rhytids, skin laxity/tone, sallowness/yellowing, and overall features. Subjective questionnaires (84.2% greater than control) and photographic assessments (57.9% greater than control) also showed statistically significant improvements.
Traikovich SS Arch Otolaryngol Head Neck Surg, 1999. PMID 10522500
1999 / Randomized controlled trial
A 16-week randomized controlled trial evaluated 156 adults aged 50 years or older with major depressive disorder assigned to aerobic exercise, sertraline hydrochloride, or combination therapy. After 16 weeks, depression scores on HAM-D and BDI did not differ statistically among groups (P = .67), and all arms showed significant reductions. Medication produced the fastest initial response, while combination therapy showed quicker early improvement among participants who started with less severe symptoms.
Blumenthal JA, Babyak MA, Moore KA, et al. Arch Intern Med, 1999. PMID 10547175
1997 / Double-blind, placebo-controlled, randomized multicenter trial
A 2-year randomized trial assigned 341 patients with moderate Alzheimer's disease to receive selegiline (10 mg/day), alpha-tocopherol (vitamin E, 2000 IU/day), both, or placebo. In unadjusted analyses, there was no statistically significant difference in outcomes among the four groups. After adjusting for baseline Mini-Mental State Examination scores, significant delays in time to the primary outcome were observed for selegiline (median 655 days, P=0.012), alpha-tocopherol (median 670 days, P=0.001), and combination therapy (median 585 days, P=0.049) compared with placebo (median 440 days).
Sano M, Ernesto C, Thomas RG, et al. N Engl J Med, 1997. PMID 9110909
1997 / Randomized, double-blind, placebo-controlled trial
A randomized, double-blind, placebo-controlled study evaluated the effect of vitamin E supplementation (60, 200, or 800 mg/d vs. placebo) for 235 days in 88 healthy elderly subjects. Subjects consuming 200 mg/d showed a 65% increase in DTH and a 6-fold increase in antibody titer to hepatitis B compared to placebo (17% and 3-fold), 60-mg/d (41% and 3-fold), and 800-mg/d (49% and 2.5-fold) groups, as well as a significant increase in tetanus antibody titer. Vitamin E had no effect on diphtheria antibody titer, immunoglobulin levels, T- and B-cell counts, or autoantibody levels.
Meydani SN, Meydani M, Blumberg JB, et al. JAMA, 1997. PMID 9134944
1997 / Interventional feeding trial
Thirteen subjects modified their diets for up to 15 weeks with additions of spinach (60 g), corn (150 g), or both to evaluate changes in retinal macular pigment (MP) density and serum carotenoids. Among subjects fed spinach or spinach and corn, eight 'retinal responders' showed mean increases of 33% in serum lutein and 19% in MP density, two showed increased serum lutein (mean 31%) but decreased MP density (mean -11%), and one showed no changes in serum carotenoids or MP density. Of two subjects fed only corn, one had a 70% increase in serum zeaxanthin and a 25% increase in MP density. Increases in MP density were observed within 4 weeks and remained elevated for at least several months after resuming an unmodified diet.
Hammond BR, Johnson EJ, Russell RM, et al. Invest Ophthalmol Vis Sci, 1997. PMID 9286268
1996 / Open-label pilot trial
An open-label trial evaluated nicotinamide adenine dinucleotide (NADH) medication in 17 patients with dementia of the Alzheimer type for 8 to 12 weeks. All evaluated patients showed improvement in cognitive dysfunction, with Mini-Mental State Examination scores improving by a mean of 8.35 points (range: 6 to 14 points) and Global Deterioration Scale scores improving by a mean of 1.82 (range: 1 to 2 points). No side effects or adverse effects were reported during observation periods exceeding a year in some patients. The authors noted that this pilot study does not allow definitive conclusions and that a double-blind placebo-controlled study is necessary.
Birkmayer JG Ann Clin Lab Sci, 1996. PMID 8834355
1995 / Comparative longitudinal study
Twenty-seven elderly individuals were assigned to three groups: no therapy (n = 14), dietary counseling alone (n = 9), or dietary instruction for six months plus hyperlipidemic medication for 18 months (n = 4). Group 1 showed a statistically significant increase in total cholesterol (P <= 0.001). Groups 2 (P <= 0.001) and 3 (P <= 0.05) had significant reductions in total cholesterol during dietary counseling, though this effect was blunted in group 3 after dietary counseling ended. Triglyceride reductions were significant only in group 2 (P <= 0.001).
Fleming RM, Ketchum K, Fleming DM, et al. Angiology, 1995. PMID 7495312
1993 / Randomized controlled trial with cross-sectional comparison
Thirty-two sedentary elderly women (67-85 years old) were randomized to 12 weeks of walking or a calisthenic control, with 12 highly conditioned elderly women active in endurance competitions recruited for baseline comparisons. Twelve weeks of moderate cardiorespiratory exercise improved VO2max in sedentary subjects by 12.6%, but did not improve NK cell activity or T cell function. During the 12-week study, URTI incidence was lowest in the highly conditioned group, intermediate in the walking group, and highest in the calisthenic group (chi-square = 6.36, P = 0.042).
Nieman DC, Henson DA, Gusewitch G, et al. Med Sci Sports Exerc, 1993. PMID 8350705
1992 / Randomized controlled trial
In an 18-month randomized trial, 3,270 ambulatory women (mean age 84 years) received daily supplementation with 1.2 g elemental calcium plus 800 IU vitamin D3 or a double placebo. Calcium and vitamin D3 reduced hip fractures by 43 percent (P = 0.043) and total nonvertebral fractures by 32 percent (P = 0.015). Proximal femur bone density rose 2.7 percent with active treatment and decreased 4.6 percent in the placebo group (P < 0.001).
Chapuy MC, Arlot ME, Duboeuf F, et al. N Engl J Med, 1992. PMID 1331788
1992 / Pre-post interventional study
Eight subjects (4 women, 4 men) inside Biosphere 2 consumed a low-calorie (average 1780 kcal/day), low-fat (10% of calories), nutrient-dense diet from internal crops. Over 6 months, significant changes included weight decreases from 74 to 62 kg in men and 61 to 54 kg in women, and mean systolic/diastolic blood pressure falling from 109/74 to 89/58 mmHg. Total serum cholesterol dropped from 191 +/- 11 to 123 +/- 9 mg/dl (a 36% mean reduction) with HDL moving from 62 +/- 8 to 38 +/- 5 mg/dl (risk ratio unchanged). Fasting glucose declined from 92 to 74 mg/dl, leukocyte count fell from 6.7 to 4.7 x 10(9) cells/L, and triglycerides shifted from 139 to 96 mg/dl in men and 78 to 114 mg/dl in women.
Walford RL, Harris SB, Gunion MW Proc Natl Acad Sci U S A, 1992. PMID 1454844
1990 / Interventional before-and-after study
Twelve healthy young and old individuals were assessed before and after 21-28 days on a high-carbohydrate, high-fiber (HCF) diet. The diet significantly lowered fasting glucose (from 5.3 +/- 0.2 to 5.1 +/- 0.1 mmol/L, p < 0.01) and insulin (from 66.0 +/- 7.9 to 49.5 +/- 5.7 pmol/L, p < 0.01). Fasting serum cholesterol fell from 5.17 +/- 0.18 to 3.80 +/- 0.20 mmol/L (p < 0.01) in young participants and from 6.15 +/- 0.52 to 4.99 +/- 0.49 mmol/L (p < 0.01) in older participants. Glucose disposal rates increased from 18.87 +/- 1.66 to 23.87 +/- 2.78 mumol.kg-1.min-1 (p < 0.02), while fasting triglycerides, basal hepatic glucose output (HGO), and insulin suppression of HGO remained unchanged.
Fukagawa NK, Anderson JW, Hageman G, et al. Am J Clin Nutr, 1990. PMID 2168124
1985 / Clinical trial
Forty patients aged 39 to 70 years affected by presbycusis (associated with transmission defects in 7 cases) were treated with vitamins A and E for 28-48 days. At the end of treatment, investigators observed an improvement in symptoms and, in some cases, in the audiometric record.
Romeo G, Giorgetti M Acta Vitaminol Enzymol, 1985. PMID 3898779